CISNE Score: Specifically designed for stable febrile neutropenia in solid tumor patients. Validates the safety of outpatient management.
Complication Risk Layer
1.1%
Severe complication rate
Verified
Last Review: 2026-07-17
| Score 0 (Level I) | Low Risk (~1.1% complications). Outpatient therapy possible. |
| Score 1–2 (Level II) | Intermediate Risk (~6.2% complications). |
| Score ≥ 3 (Level III) | High Risk (~36% complications). Inpatient monitoring required. |
Carmona-Bayonas A et al. • J Clin Oncol.. 2015;33(5):465-71. Validated specifically for the solid tumor population in a multicenter trial.
Last Comprehensive Review: 2026-07-17
Clinical Context
We think this has broad domain relevance to CISNE Score for Febrile Neutropenia.
Clinical Context
We think this has broad domain relevance to CISNE Score for Febrile Neutropenia.
Clinical Context
We think this has broad domain relevance to CISNE Score for Febrile Neutropenia.
